Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
Multiple locations, including Los Alamitos
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In ChicagoThis study is completed. It focuses on schizophrenia and currently lists study information in Canada, Israel, Singapore, the United Kingdom, and the United States.
Multiple locations, including AnchorageThis study is completed. It focuses on bipolarity and currently lists study information in China.
In ShanghaiThis study is completed in the United States. It is testing OLZ/SAM for Bipolarity.
Multiple locations, including DecaturThis study was terminated in the United Kingdom, in Germany, and in the Netherlands. It is testing Phase 2 Clinical Trial of GH001 for Bipolarity.
Multiple locations, including DresdenThis study is completed. It focuses on bipolarity and currently lists study information in Italy.
Multiple locations, including San Bonifacio
This study is active but not recruiting. It focuses on anxiety and currently lists study information in Sweden.
In StockholmThis study is completed. It focuses on bipolarity and currently lists study information in Turkey.
In IstanbulThis study is completed. It focuses on depression and currently lists study information in Global.
In GlobalThis study is completed. It focuses on depression and currently lists study information in the United States.
In Palo AltoThis study was withdrawn in Global. It is testing sublingual Dexmedetomidine for Schizophrenia.
In GlobalHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.